Skip to main content
. 2015 Jul 16;30(12):2039–2045. doi: 10.1093/ndt/gfv225

Table 2.

The rate of decline in renal function (95% CI)

CKD III–V (n = 2466) CKD III (n = 618) CKD IV (n = 1507) CKD V (n = 341)
Mean declinea −1.48 (−1.65; −1.31) −1.52 (−1.96; −1.08) −1.52 (−1.72; −1.32) −1.19 (−1.75; −0.64)
Change in eGFR decline per mg/dL increase in UA at baseline (negative = extra decline)a
 Crude 0.08 (−0.01; 0.17) −0.09 (−0.31; 0.12) 0.14 (0.03; 0.26) 0.10 (−0.17; 0.37) 0.20*
 Adjustedb 0.09 (−0.01; 0.19) −0.09 (−0.30; 0.13) 0.16 (0.04; 0.28) 0.18 (−0.09; 0.45) 0.12

aIn mL/min/1.73 m2 per year.

bAdjusted for age, sex, PRD, BMI, MAP, protein-restricted diet, diuretics use, statin use and UA-lowering medication use, diabetes, arrhythmia, dementia, CVD, IHD, hypertension, pulmonary disease and CHF.

*P-value for difference in the change in the rate of renal function decline between CKD stages.